TREA

79406165 - BICYCLE

Follow

Information

  • Trademark
  • 79406165
  • Serial Number
    79406165
  • Filing Date
    May 21, 2024
    a year ago
  • Transaction Date
    July 22, 2025
    7 months ago
  • Status Date
    July 21, 2025
    7 months ago
  • Published for Opposition Date
    March 18, 2025
    11 months ago
  • Location Date
    February 27, 2025
    a year ago
  • Status Code
    774
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BERGER, MAGDALENA
  • Attorney Docket Number
    B17012002200
    Attorney Name
    CHRISTINA M. LICURSI
    Law Office Assigned Location Code
    N50
  • Owners
Information
Mark Drawing Code
5
Mark Identification
BICYCLE
Case File Statements
  • GS0051: Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumours, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use; pharmaceutical preparations for use as clinical imaging agents for positron emission tomography use
  • GS0441: Medical services; medical testing for diagnostic or treatment purposes; healthcare services; pharmaceutical services, namely, pharmaceutical compounding services; medical consulting services; advisory services relating to pharmaceuticals, namely, pharmaceutical consultation and providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consultancy and information services relating to pharmaceuticals, namely, pharmaceutical consultation and providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical compounding services in the field of oncology; pharmaceutical compounding services in the field of ophthalmology; pharmaceutical compounding services in the field of neurology; pharmaceutical compounding services in the field of anti-infectives; pharmaceutical compounding services in connection with respiratory disease; pharmaceutical compounding services in connection with cardiovascular disease; pharmaceutical compounding services in connection with metabolic disease; pharmaceutical compounding services in connection with the treatment and/or prevention of viral infections; pharmaceutical compounding services in connection with diagnostics and imaging; pharmaceutical compounding services in connection with renal disease; pharmaceutical compounding services in connection with gastrointestinal disease; pharmaceutical compounding services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid
  • GS0421: Scientific research; scientific study and research in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; laboratory research services in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; providing information, consultancy and advisory services relating to the design, planning and implementation of scientific and clinical research for others
Case File Event Statements
  • 10/10/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 10/15/2024 - a year ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 10/15/2024 - a year ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/15/2024 - a year ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/16/2024 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/29/2024 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/21/2025 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/25/2024 - a year ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/26/2024 - a year ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/10/2024 - a year ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/10/2024 - a year ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/21/2025 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/21/2025 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/25/2025 - a year ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/12/2025 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/26/2025 - 11 months ago
    20 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/26/2025 - 11 months ago
    22 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 3/26/2025 - 11 months ago
    18 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/26/2025 - 11 months ago
    21 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/18/2025 - 11 months ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/18/2025 - 11 months ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/26/2025 - 11 months ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/26/2025 - 11 months ago
    19 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/14/2025 - 11 months ago
    24 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 7/17/2025 - 7 months ago
    26 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 7/17/2025 - 7 months ago
    25 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 7/21/2025 - 7 months ago
    27 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 7/21/2025 - 7 months ago
    28 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP